Myeloma protein(M protein) is the most common means of detection, but the detection of M protein had a plateau, and the sensitivity of peripheral blood(PB) M protein level detection to monitor the therapeutic effect still needs to be improved. Some studies have suggest that specific chromosomal abnormalities may influenced the outcome of MM patients. Here, MYOM2 is linked to Miyoshi myopathy.